NEOG Strangle Strategy
NEOG (Neogen Corporation), in the Healthcare sector, (Medical - Diagnostics & Research industry), listed on NASDAQ.
Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy.
NEOG (Neogen Corporation) trades in the Healthcare sector, specifically Medical - Diagnostics & Research, with a market capitalization of approximately $2.09B, a beta of 1.80 versus the broader market, a 52-week range of 4.56-11.43, average daily share volume of 2.5M, a public-listing history dating back to 1989, approximately 3K full-time employees. These structural characteristics shape how NEOG stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.80 indicates NEOG has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a strangle on NEOG?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current NEOG snapshot
As of June 30, 2026, spot at $8.89, ATM IV 10.80%, IV rank 0.93%, expected move 3.10%. The strangle on NEOG below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this strangle structure on NEOG specifically: NEOG IV at 10.80% is on the cheap side of its 1-year range, which favors premium-buying structures like a NEOG strangle, with a market-implied 1-standard-deviation move of approximately 3.10% (roughly $0.28 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated NEOG expiries trade a higher absolute premium for lower per-day decay. Position sizing on NEOG should anchor to the underlying notional of $8.89 per share and to the trader's directional view on NEOG stock.
NEOG strangle setup
The NEOG strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With NEOG near $8.89, the first option leg uses a $9.33 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed NEOG chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 NEOG shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $9.33 | N/A |
| Buy 1 | Put | $8.45 | N/A |
NEOG strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
NEOG strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on NEOG. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on NEOG
Strangles on NEOG are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the NEOG chain.
NEOG thesis for this strangle
The market-implied 1-standard-deviation range for NEOG extends from approximately $8.61 on the downside to $9.17 on the upside. A NEOG long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current NEOG IV rank near 0.93% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on NEOG at 10.80%. As a Healthcare name, NEOG options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to NEOG-specific events.
NEOG strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. NEOG positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move NEOG alongside the broader basket even when NEOG-specific fundamentals are unchanged. Always rebuild the position from current NEOG chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on NEOG?
- A strangle on NEOG is the strangle strategy applied to NEOG (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With NEOG stock trading near $8.89, the strikes shown on this page are snapped to the nearest listed NEOG chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are NEOG strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the NEOG strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 10.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a NEOG strangle?
- The breakeven for the NEOG strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current NEOG market-implied 1-standard-deviation expected move is approximately 3.10%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on NEOG?
- Strangles on NEOG are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the NEOG chain.
- How does current NEOG implied volatility affect this strangle?
- NEOG ATM IV is at 10.80% with IV rank near 0.93%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.